ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastroparesis Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-20M8974
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gastroparesis Drugs Market Outlook 2022
BUY CHAPTERS

Global Gastroparesis Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-20M8974
Report
June 2025
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cadila Pharmaceuticals
Sanofi
TEVA
Johnson & Johnson
Pfizer Inc
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
ANI Pharmaceuticals
Sumitomo

Gastroparesis Drugs Market Size

In 2024, the global market size of Gastroparesis Drugs was estimated to be worth US$ 6152 million and is forecast to reach approximately US$ 8227 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.

Gastroparesis Drugs Market

Gastroparesis Drugs Market

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Drugs.
The Gastroparesis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastroparesis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroparesis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Gastroparesis Drugs Market Report

Report Metric Details
Report Name Gastroparesis Drugs Market
Forecasted market size in 2031 approximately US$ 8227 million
CAGR 4.3%
Forecasted years 2025 - 2031
Segment by Type
  • Prokinetic Agents
  • Antiemetic Agents
  • Others
Segment by Application
  • Diabetic Gastroparesis
  • Idiopathic Gastroparesis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm, Ani Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Gastroparesis Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Gastroparesis Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastroparesis Drugs sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Gastroparesis Drugs Market size in 2031?

Ans: The Gastroparesis Drugs Market size in 2031 will be approximately US$ 8227 million.

Who are the main players in the Gastroparesis Drugs Market report?

Ans: The main players in the Gastroparesis Drugs Market are Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm, Ani Pharmaceuticals

What are the Application segmentation covered in the Gastroparesis Drugs Market report?

Ans: The Applications covered in the Gastroparesis Drugs Market report are Diabetic Gastroparesis, Idiopathic Gastroparesis

What are the Type segmentation covered in the Gastroparesis Drugs Market report?

Ans: The Types covered in the Gastroparesis Drugs Market report are Prokinetic Agents, Antiemetic Agents, Others

1 Study Coverage
1.1 Gastroparesis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gastroparesis Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastroparesis Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gastroparesis Drugs Market Size Estimates and Forecasts
2.1.1 Global Gastroparesis Drugs Revenue 2020-2031
2.1.2 Global Gastroparesis Drugs Sales 2020-2031
2.2 Gastroparesis Drugs Market Size by Region: 2024 Versus 2031
2.3 Gastroparesis Drugs Sales by Region (2020-2031)
2.3.1 Global Gastroparesis Drugs Sales by Region: 2020-2025
2.3.2 Global Gastroparesis Drugs Sales Forecast by Region (2026-2031)
2.3.3 Global Gastroparesis Drugs Sales Market Share by Region (2020-2031)
2.4 Gastroparesis Drugs Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Gastroparesis Drugs Revenue by Region: 2020-2025
2.4.2 Global Gastroparesis Drugs Revenue Forecast by Region (2026-2031)
2.4.3 Global Gastroparesis Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Gastroparesis Drugs Sales by Type (2020-2031)
3.1.1.1 Global Gastroparesis Drugs Sales Volume by Type (2020-2031)
3.1.1.2 Global Gastroparesis Drugs Sales Market Share by Type (2020-2031)
3.1.2 Global Gastroparesis Drugs Revenue by Type (2020-2031)
3.1.2.1 Global Gastroparesis Drugs Revenue by Type (2020-2031)
3.1.2.2 Global Gastroparesis Drugs Revenue Market Share by Type (2020-2031)
3.1.3 Gastroparesis Drugs Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Gastroparesis Drugs Sales by Application (2020-2031)
3.2.1.1 Global Gastroparesis Drugs Sales Volume by Application (2020-2031)
3.2.1.2 Global Gastroparesis Drugs Sales Market Share by Application (2020-2031)
3.2.2 Global Gastroparesis Drugs Revenue by Application (2020-2031)
3.2.2.1 Global Gastroparesis Drugs Revenue by Application (2020-2031)
3.2.2.2 Global Gastroparesis Drugs Revenue Market Share by Application (2020-2031)
3.2.3 Gastroparesis Drugs Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prokinetic Agents of Gastroparesis Drugs Revenue Market Share by Application
3.3.2 Antiemetic Agents of Gastroparesis Drugs Revenue Market Share by Application
3.3.3 Others of Gastroparesis Drugs Revenue Market Share by Application
4 Global Gastroparesis Drugs by Manufacturers
4.1 Global Top Gastroparesis Drugs Manufacturers by Sales (2020-2025)
4.1.1 Global Gastroparesis Drugs Sales by Manufacturer (2020-2025)
4.1.2 Global Gastroparesis Drugs Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Gastroparesis Drugs Manufacturers by Revenue (2020-2025)
4.2.1 Global Gastroparesis Drugs Revenue by Manufacturer (2020-2025)
4.2.2 Global Gastroparesis Drugs Revenue Share by Manufacturer (2020-2025)
4.3 Global Gastroparesis Drugs Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Gastroparesis Drugs Manufacturers Covered: Ranking by Revenue
4.4.2 Global Gastroparesis Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Gastroparesis Drugs Manufacturing Base Distribution, Product Type
4.5.1 Gastroparesis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Gastroparesis Drugs Market
4.5.3 Manufacturers Gastroparesis Drugs Product Type and Application
4.5.4 Prokinetic Agents Market Sales of Gastroparesis Drugs by Manufacturer
4.5.5 Antiemetic Agents Market Sales of Gastroparesis Drugs by Manufacturer
4.5.6 Others Market Sales of Gastroparesis Drugs by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sumitomo
5.1.1 Sumitomo Company Information
5.1.2 Sumitomo Description, Business Overview
5.1.3 Sumitomo Gastroparesis Drugs Products Offered
5.1.4 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sumitomo Gastroparesis Drugs Sales by Product in 2024
5.1.6 Sumitomo Gastroparesis Drugs Sales by Application in 2024
5.1.7 Sumitomo Gastroparesis Drugs Sales by Geographic Area in 2024
5.1.8 Sumitomo Recent Developments
5.2 Cadila Pharmaceuticals
5.2.1 Cadila Pharmaceuticals Company Information
5.2.2 Cadila Pharmaceuticals Description, Business Overview
5.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Products Offered
5.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Cadila Pharmaceuticals Gastroparesis Drugs Sales by Product in 2024
5.2.6 Cadila Pharmaceuticals Gastroparesis Drugs Sales by Application in 2024
5.2.7 Cadila Pharmaceuticals Gastroparesis Drugs Sales by Geographic Area in 2024
5.2.8 Cadila Pharmaceuticals Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Gastroparesis Drugs Products Offered
5.3.4 Sanofi Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Gastroparesis Drugs Sales by Product in 2024
5.3.6 Sanofi Gastroparesis Drugs Sales by Application in 2024
5.3.7 Sanofi Gastroparesis Drugs Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Teva
5.4.1 Teva Company Information
5.4.2 Teva Description, Business Overview
5.4.3 Teva Gastroparesis Drugs Products Offered
5.4.4 Teva Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Teva Gastroparesis Drugs Sales by Product in 2024
5.4.6 Teva Gastroparesis Drugs Sales by Application in 2024
5.4.7 Teva Gastroparesis Drugs Sales by Geographic Area in 2024
5.4.8 Teva Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Company Information
5.5.2 Johnson & Johnson Description, Business Overview
5.5.3 Johnson & Johnson Gastroparesis Drugs Products Offered
5.5.4 Johnson & Johnson Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Johnson & Johnson Gastroparesis Drugs Sales by Product in 2024
5.5.6 Johnson & Johnson Gastroparesis Drugs Sales by Application in 2024
5.5.7 Johnson & Johnson Gastroparesis Drugs Sales by Geographic Area in 2024
5.5.8 Johnson & Johnson Recent Developments
5.6 Pfizer
5.6.1 Pfizer Company Information
5.6.2 Pfizer Description, Business Overview
5.6.3 Pfizer Gastroparesis Drugs Products Offered
5.6.4 Pfizer Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Pfizer Gastroparesis Drugs Sales by Product in 2024
5.6.6 Pfizer Gastroparesis Drugs Sales by Application in 2024
5.6.7 Pfizer Gastroparesis Drugs Sales by Geographic Area in 2024
5.6.8 Pfizer Recent Developments
5.7 Kyowa Kirin Pharmaceuticals
5.7.1 Kyowa Kirin Pharmaceuticals Company Information
5.7.2 Kyowa Kirin Pharmaceuticals Description, Business Overview
5.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Products Offered
5.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales by Product in 2024
5.7.6 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales by Application in 2024
5.7.7 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales by Geographic Area in 2024
5.7.8 Kyowa Kirin Pharmaceuticals Recent Developments
5.8 Hanmi Pharm
5.8.1 Hanmi Pharm Company Information
5.8.2 Hanmi Pharm Description, Business Overview
5.8.3 Hanmi Pharm Gastroparesis Drugs Products Offered
5.8.4 Hanmi Pharm Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Hanmi Pharm Gastroparesis Drugs Sales by Product in 2024
5.8.6 Hanmi Pharm Gastroparesis Drugs Sales by Application in 2024
5.8.7 Hanmi Pharm Gastroparesis Drugs Sales by Geographic Area in 2024
5.8.8 Hanmi Pharm Recent Developments
5.9 Ani Pharmaceuticals
5.9.1 Ani Pharmaceuticals Company Information
5.9.2 Ani Pharmaceuticals Description, Business Overview
5.9.3 Ani Pharmaceuticals Gastroparesis Drugs Products Offered
5.9.4 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Ani Pharmaceuticals Gastroparesis Drugs Sales by Product in 2024
5.9.6 Ani Pharmaceuticals Gastroparesis Drugs Sales by Application in 2024
5.9.7 Ani Pharmaceuticals Gastroparesis Drugs Sales by Geographic Area in 2024
5.9.8 Ani Pharmaceuticals Recent Developments
6 North America
6.1 North America Gastroparesis Drugs Market Size YoY Growth 2020-2031
6.2 North America Gastroparesis Drugs Market Facts & Figures by Country
6.2.1 North America Gastroparesis Drugs Sales by Country (2020-2031)
6.2.2 North America Gastroparesis Drugs Revenue by Country (2020-2031)
6.3 North America Gastroparesis Drugs Sales by Type (2020-2025)
6.4 North America Gastroparesis Drugs Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Gastroparesis Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Gastroparesis Drugs Market Facts & Figures by Region
7.2.1 Asia-Pacific Gastroparesis Drugs Sales by Region (2020-2031)
7.2.2 Asia-Pacific Gastroparesis Drugs Revenue by Region (2020-2031)
7.3 Asia-Pacific Gastroparesis Drugs Sales by Type (2020-2025)
7.4 Asia-Pacific Gastroparesis Drugs Sales by Application (2020-2025)
8 Europe
8.1 Europe Gastroparesis Drugs Market Size YoY Growth 2020-2031
8.2 Europe Gastroparesis Drugs Market Facts & Figures by Country
8.2.1 Europe Gastroparesis Drugs Sales by Country (2020-2031)
8.2.2 Europe Gastroparesis Drugs Revenue by Country (2020-2031)
8.3 Europe Gastroparesis Drugs Sales by Type (2020-2025)
8.4 Europe Gastroparesis Drugs Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Gastroparesis Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Gastroparesis Drugs Market Facts & Figures by Country
9.2.1 Latin America Gastroparesis Drugs Sales by Country (2020-2031)
9.2.2 Latin America Gastroparesis Drugs Revenue by Country (2020-2031)
9.3 Latin America Gastroparesis Drugs Sales by Type (2020-2025)
9.4 Latin America Gastroparesis Drugs Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Gastroparesis Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Gastroparesis Drugs Market Facts & Figures by Country
10.2.1 Middle East and Africa Gastroparesis Drugs Sales by Country (2020-2031)
10.2.2 Middle East and Africa Gastroparesis Drugs Revenue by Country (2020-2031)
10.3 Middle East and Africa Gastroparesis Drugs Sales by Type (2020-2025)
10.4 Middle East and Africa Gastroparesis Drugs Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Gastroparesis Drugs Supply Chain Analysis
11.2 Gastroparesis Drugs Key Raw Materials and Upstream Suppliers
11.3 Gastroparesis Drugs Clients Analysis
11.4 Gastroparesis Drugs Sales Channel and Sales Model Analysis
11.4.1 Gastroparesis Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Gastroparesis Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Gastroparesis Drugs Distributors
12 Gastroparesis Drugs Market Dynamics
12.1 Gastroparesis Drugs Industry Trends
12.2 Gastroparesis Drugs Market Drivers
12.3 Gastroparesis Drugs Market Challenges
12.4 Gastroparesis Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Cadila Pharmaceuticals
Sanofi
TEVA
Johnson & Johnson
Pfizer Inc
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
ANI Pharmaceuticals
Sumitomo
List of Tables
 Table 1. Global Gastroparesis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Gastroparesis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Gastroparesis Drugs Sales by Region (2020-2025) & (Kg)
 Table 5. Global Gastroparesis Drugs Sales Forecast by Region (2026-2031) & (Kg)
 Table 6. Global Gastroparesis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Gastroparesis Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Gastroparesis Drugs Sales Volume by Type (2020-2025) & (Kg)
 Table 9. Global Gastroparesis Drugs Sales Volume by Type (2026-2031) & (Kg)
 Table 10. Global Gastroparesis Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Gastroparesis Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Gastroparesis Drugs Sales Volume by Application (2020-2025) & (Kg)
 Table 13. Global Gastroparesis Drugs Sales Volume by Application (2026-2031) & (Kg)
 Table 14. Global Gastroparesis Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Gastroparesis Drugs Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Gastroparesis Drugs Sales by Manufacturer (2020-2025) & (Kg)
 Table 17. Global Gastroparesis Drugs Sales Share by Manufacturer (2020-2025)
 Table 18. Gastroparesis Drugs Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Gastroparesis Drugs Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Gastroparesis Drugs Price (2020-2025) & (US$/mg)
 Table 21. Ranking of Global Top Gastroparesis Drugs Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Gastroparesis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Drugs as of 2024)
 Table 24. Gastroparesis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Gastroparesis Drugs Market
 Table 26. Manufacturers Gastroparesis Drugs Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Sumitomo Company Information
 Table 29. Sumitomo Description and Business Overview
 Table 30. Sumitomo Gastroparesis Drugs Product
 Table 31. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 32. Sumitomo Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 33. Sumitomo Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 34. Sumitomo Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 35. Sumitomo Recent Developments
 Table 36. Cadila Pharmaceuticals Company Information
 Table 37. Cadila Pharmaceuticals Description and Business Overview
 Table 38. Cadila Pharmaceuticals Gastroparesis Drugs Product
 Table 39. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 40. Cadila Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 41. Cadila Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 42. Cadila Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 43. Cadila Pharmaceuticals Recent Developments
 Table 44. Sanofi Company Information
 Table 45. Sanofi Description and Business Overview
 Table 46. Sanofi Gastroparesis Drugs Product
 Table 47. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 48. Sanofi Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 49. Sanofi Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 50. Sanofi Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 51. Sanofi Recent Developments
 Table 52. Teva Company Information
 Table 53. Teva Description and Business Overview
 Table 54. Teva Gastroparesis Drugs Product
 Table 55. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 56. Teva Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 57. Teva Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 58. Teva Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 59. Teva Recent Developments
 Table 60. Johnson & Johnson Company Information
 Table 61. Johnson & Johnson Description and Business Overview
 Table 62. Johnson & Johnson Gastroparesis Drugs Product
 Table 63. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 64. Johnson & Johnson Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 65. Johnson & Johnson Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 66. Johnson & Johnson Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 67. Johnson & Johnson Recent Developments
 Table 68. Pfizer Company Information
 Table 69. Pfizer Description and Business Overview
 Table 70. Pfizer Gastroparesis Drugs Product
 Table 71. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 72. Pfizer Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 73. Pfizer Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 74. Pfizer Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 75. Pfizer Recent Developments
 Table 76. Kyowa Kirin Pharmaceuticals Company Information
 Table 77. Kyowa Kirin Pharmaceuticals Description and Business Overview
 Table 78. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product
 Table 79. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 80. Kyowa Kirin Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 81. Kyowa Kirin Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 82. Kyowa Kirin Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 83. Kyowa Kirin Pharmaceuticals Recent Developments
 Table 84. Hanmi Pharm Company Information
 Table 85. Hanmi Pharm Description and Business Overview
 Table 86. Hanmi Pharm Gastroparesis Drugs Product
 Table 87. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 88. Hanmi Pharm Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 89. Hanmi Pharm Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 90. Hanmi Pharm Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 91. Hanmi Pharm Recent Developments
 Table 92. Ani Pharmaceuticals Company Information
 Table 93. Ani Pharmaceuticals Description and Business Overview
 Table 94. Ani Pharmaceuticals Gastroparesis Drugs Product
 Table 95. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 96. Ani Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Product in 2024
 Table 97. Ani Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Application in 2024
 Table 98. Ani Pharmaceuticals Sales Proportion of Gastroparesis Drugs by Geographic Area in 2024
 Table 99. Ani Pharmaceuticals Recent Developments
 Table 100. North America Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
 Table 101. North America Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
 Table 102. North America Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 103. North America Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 104. North America Gastroparesis Drugs Sales by Type (2020-2025) & (Kg)
 Table 105. North America Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
 Table 106. Asia-Pacific Gastroparesis Drugs Sales by Region (2020-2025) & (Kg)
 Table 107. Asia-Pacific Gastroparesis Drugs Sales by Region (2026-2031) & (Kg)
 Table 108. Asia-Pacific Gastroparesis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 109. Asia-Pacific Gastroparesis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 110. Asia-Pacific Gastroparesis Drugs Sales by Type (2020-2025) & (Kg)
 Table 111. Asia-Pacific Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
 Table 112. Europe Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
 Table 113. Europe Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
 Table 114. Europe Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 115. Europe Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 116. Europe Gastroparesis Drugs Sales by Type (2020-2025) & (Kg)
 Table 117. Europe Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
 Table 118. Latin America Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
 Table 119. Latin America Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
 Table 120. Latin America Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 121. Latin America Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 122. Latin America Gastroparesis Drugs Sales by Type (2020-2025) & (Kg)
 Table 123. Latin America Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
 Table 124. Middle East and Africa Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
 Table 125. Middle East and Africa Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
 Table 126. Middle East and Africa Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 127. Middle East and Africa Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 128. Middle East and Africa Gastroparesis Drugs Sales by Type (2020-2025) & (Kg)
 Table 129. Middle East and Africa Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
 Table 130. Gastroparesis Drugs Key Raw Materials, Industry Status and Trend
 Table 131. Gastroparesis Drugs Key Raw Materials and Upstream Suppliers
 Table 132. Gastroparesis Drugs Clients Status and Trend
 Table 133. Gastroparesis Drugs Typical Clients
 Table 134. Gastroparesis Drugs Distributors
 Table 135. Gastroparesis Drugs Market Trends
 Table 136. Gastroparesis Drugs Market Drivers
 Table 137. Gastroparesis Drugs Market Challenges
 Table 138. Gastroparesis Drugs Market Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Gastroparesis Drugs Product Picture
 Figure 2. Global Gastroparesis Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Gastroparesis Drugs Sales Market Share by Type in 2024 & 2031
 Figure 4. Prokinetic Agents Product Picture
 Figure 5. Antiemetic Agents Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Gastroparesis Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Gastroparesis Drugs Sales Market Share by Application in 2024 & 2031
 Figure 9. Diabetic Gastroparesis
 Figure 10. Idiopathic Gastroparesis
 Figure 11. Gastroparesis Drugs Report Years Considered
 Figure 12. Global Gastroparesis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Gastroparesis Drugs Market Size 2020-2031 (US$ Million)
 Figure 14. Global Gastroparesis Drugs Sales 2020-2031 (Kg)
 Figure 15. Global Gastroparesis Drugs Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Gastroparesis Drugs Revenue Market Share by Region (2020-2031)
 Figure 17. Global Gastroparesis Drugs Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Gastroparesis Drugs Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Gastroparesis Drugs Average Selling Price (ASP) by Type (2020-2025) & (US$/mg)
 Figure 20. Global Gastroparesis Drugs Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Gastroparesis Drugs Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Gastroparesis Drugs Average Selling Price (ASP) by Application (2020-2025) & (US$/mg)
 Figure 23. Prokinetic Agents of Gastroparesis Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Antiemetic Agents of Gastroparesis Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Others of Gastroparesis Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Global Gastroparesis Drugs Sales Share by Manufacturer in 2024
 Figure 27. Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Prokinetic Agents Market Sales Proportion by Manufacturer in 2024
 Figure 29. Antiemetic Agents Market Sales Proportion by Manufacturer in 2024
 Figure 30. Others Market Sales Proportion by Manufacturer in 2024
 Figure 31. North America Gastroparesis Drugs Revenue 2020-2031 (US$ Million)
 Figure 32. North America Gastroparesis Drugs Sales Market Share by Type (2020-2025)
 Figure 33. North America Gastroparesis Drugs Sales Market Share by Application (2020-2025)
 Figure 34. Asia-Pacific Gastroparesis Drugs Revenue 2020-2031 (US$ Million)
 Figure 35. Asia-Pacific Gastroparesis Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia-Pacific Gastroparesis Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Gastroparesis Drugs Sales Market Share by Type (2020-2025)
 Figure 38. Asia-Pacific Gastroparesis Drugs Sales Market Share by Application (2020-2025)
 Figure 39. Europe Gastroparesis Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 40. Europe Gastroparesis Drugs Sales Market Share by Country (2020-2031)
 Figure 41. Europe Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
 Figure 42. Europe Gastroparesis Drugs Sales Market Share by Type (2020-2025)
 Figure 43. Europe Gastroparesis Drugs Sales Market Share by Application (2020-2025)
 Figure 44. Latin America Gastroparesis Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 45. Latin America Gastroparesis Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Gastroparesis Drugs Revenue Market Share by Country (2020-2025)
 Figure 47. Latin America Gastroparesis Drugs Sales Market Share by Type (2020-2025)
 Figure 48. Latin America Gastroparesis Drugs Sales Market Share by Application (2020-2025)
 Figure 49. Middle East and Africa Gastroparesis Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 50. Middle East and Africa Gastroparesis Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Gastroparesis Drugs Sales Market Share by Type (2020-2025)
 Figure 53. Middle East and Africa Gastroparesis Drugs Sales Market Share by Application (2020-2025)
 Figure 54. Gastroparesis Drugs Supply Chain (Upstream and Downstream Market)
 Figure 55. Global Production Market Share of Gastroparesis Drugs Raw Materials by Region in 2024
 Figure 56. Gastroparesis Drugs Distribution Channels
 Figure 57. Global Gastroparesis Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 58. Global Gastroparesis Drugs Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Treatment for Gastroparesis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroparesis Treatment Market Research Report 2024
Global Gastroparesis Treatment Products Market Insights Forecast to 2030
Global Idiopathic Gastroparesis Drugs Market Insights Forecast to 2030
Global Diabetic Gastroparesis Drugs Market Insights Forecast to 2030
Gastric Motility Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Gastroparesis Treatment Products Market Insights Forecast to 2030
Global Prokinetic Drug Market Insights Forecast to 2030
Global Gastrointestinal OTC Drugs Market Research Report 2024
Global OTC Gastrointestinal Products Market Research Report 2024
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Global Gastrointestinal Drugs Market Research Report 2025
Global Bromopride Market Research Report 2024
Diabetic Gastroparesis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nausea And Vomiting Treatment Market Insights Forecast to 2030
Global Peptic Ulcer Disease Medication Market Research Report 2025
Global Digestive Drugs Market Insights Forecast to 2030
Diabetic Gastroparesis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastric Cancer Drugs Market Research Report 2024
Global Stomach Medicine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions